# A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors

> **NCT07173244** · — · NOT_YET_RECRUITING · sponsor: **Tianjin First Central Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer
- Small Cell Lung Cancer
- Gastrointestinal Cancers

## Interventions

- **DRUG:** Adebrelimab

## Key facts

- **NCT ID:** NCT07173244
- **Lead sponsor:** Tianjin First Central Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2027-09
- **Final completion:** 2029-09
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173244, "A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07173244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*